These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9773613)
1. [Review of the cooperative study of Veterans' affairs on the control and complications of type 2 diabetes, especially cardiovascular diseases]. Nuttall FQ Journ Annu Diabetol Hotel Dieu; 1998; ():99-112. PubMed ID: 9773613 [No Abstract] [Full Text] [Related]
3. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out? Bartnik M; Cosentino F Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498 [No Abstract] [Full Text] [Related]
4. Management of diabetes in cardiovascular patients: diabetic heart disease. Peter R; Cox A; Evans M Heart; 2008 Mar; 94(3):369-75. PubMed ID: 18276822 [No Abstract] [Full Text] [Related]
5. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. De Taeye B; Smith LH; Vaughan DE Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823 [TBL] [Abstract][Full Text] [Related]
6. [Diabetes and hypertension. Results from the ADVANCE study]. Mehlsen J Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082 [No Abstract] [Full Text] [Related]
7. Glycaemic control and macrovascular complications of type 2 diabetes. Dandona P; Chaudhuri A Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214 [No Abstract] [Full Text] [Related]
8. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes]. Christiansen AL; Madsbad S Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999 [TBL] [Abstract][Full Text] [Related]
9. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies]. Sjöholm A Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972 [TBL] [Abstract][Full Text] [Related]
13. Glycemic targets for patients with type 2 diabetes mellitus. Hamnvik OP; McMahon GT Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966 [TBL] [Abstract][Full Text] [Related]
14. Barometer of type 2 diabetes in primary care. Metabolic control, styles of life and morbidity profile. Pérez-Manchón D; Rodríguez-Álvarez ML; Alcívar-Arteaga C; Redondo-Pico M; Ramos-Quirós E Enferm Clin; 2017; 27(6):369-374. PubMed ID: 28040315 [TBL] [Abstract][Full Text] [Related]
16. [Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus]. Zied A; Oudi M; Chahib M; Olfa E; Brahim N; Hédi M; Habib H; Borni Z; Salem M Tunis Med; 2005 Sep; 83(9):537-40. PubMed ID: 16383199 [TBL] [Abstract][Full Text] [Related]
17. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance. Tennyson GE Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408 [TBL] [Abstract][Full Text] [Related]
19. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance. Stern M Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555 [No Abstract] [Full Text] [Related]
20. Approaches to cardiovascular disease and its treatment. Bloomgarden ZT Diabetes Care; 2003 Dec; 26(12):3342-8. PubMed ID: 14633826 [No Abstract] [Full Text] [Related] [Next] [New Search]